Josh Sharp is a Boston-based partner in Nixon Peabody’s Government Investigations & White Collar Defense practice group. He represents corporations and individuals in government investigations, regulatory inquiries, and complex civil and criminal litigation. Josh’s recent work includes obtaining dismissal of a $3 billion RICO lawsuit filed in the District of Massachusetts and defending a parent in a month-long federal trial arising from the Varsity Blues investigation.
I assist clients with internal investigations, regulatory inquiries, grand jury matters, and criminal defense. I also litigate civil matters in state and federal courts.
I represent banks and broker-dealers in investigations by the Department of Justice, the SEC, FinCEN, and FINRA. I have substantial experience with the Bank Secrecy Act and FinCEN’s anti-money laundering regulations.
I represent life sciences companies and health care providers in both internal matters and Department of Justice investigations. I have significant experience with the False Claims Act, the Anti-Kickback statute and the Federal Food, Drug, and Cosmetic Act.
I represent clients in corporate immigration investigations by the Departments of Justice, Homeland Security and State. I have been involved in some of the most significant investigations in this space.
In addition to my investigations work, I regularly represent clients in state and federal courts in business litigation matters. I recently obtained dismissal with prejudice of a $3 billion RICO lawsuit filed in the District of Massachusetts.
For many years, whistleblowers have been the driving force behind corporate criminal enforcement, both through the False Claims Act and the Dodd-Frank whistleblower provisions. In January 2021, the Anti-Money Laundering Act of 2020 became law, providing for whistleblower rewards of up to 30% of monetary sanctions imposed for successful Bank Secrecy Act enforcement actions. The enhanced incentives to report anti-money laundering violations are likely to trigger further government scrutiny in this space.
Harvard College, A.B., cum laude, Phi Beta Kappa
Harvard Law School, J.D., magna cum laude
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe